Global cancer statistics, CA Cancer J Clin, vol.65, pp.87-108, 2012. ,
, Nat Rev Dis Primers, vol.2, p.16018, 2016.
Intratumor molecular and phenotypic diversity in hepatocellular carcinoma, Clin Cancer Res, vol.21, pp.1786-1788, 2015. ,
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches, Nat Rev Gastroenterol Hepatol, vol.14, pp.203-217, 2017. ,
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma, Gastroenterology, vol.150, pp.835-853, 2016. ,
Gd-EOB-DTPAenhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma, vol.60, pp.1674-1685, 2014. ,
Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging, Sci Rep, vol.7, p.2452, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01542017
OATP1B3 expression is strongly associated with Wnt/?-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma, J Hepatol, vol.61, pp.1080-1087, 2014. ,
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma, Gastroenterology, vol.149, pp.1226-1239, 2015. ,
Advances in targeted therapies for hepatocellular carcinoma in the genomic era, Nat Rev Clin Oncol, vol.12, pp.408-424, 2015. ,
SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, vol.359, pp.378-390, 2008. ,
Sorafenib in liver cancer--just the beginning, N Engl J Med, vol.359, pp.420-422, 2008. ,
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond, Cancer Treat Rev, vol.68, pp.16-24, 2018. ,
, Electronic address: easloffice@easloffice.eu.; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma, J Hepatol, vol.69, pp.182-236, 2018.
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma, Gastroenterology, vol.151, pp.1155-1163, 2016. ,
Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?, Gastroenterology, vol.152, pp.1624-1625, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01520290
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial, Lancet Oncol, vol.18, pp.1624-1636, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01727346
Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development ,
, Gene Expr, vol.16, pp.77-84, 2014.
Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N Engl J Med, vol.359, pp.1995-2004, 2008. ,
Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma, Gastroenterology, vol.144, pp.512-527, 2013. ,
Cancer genome landscapes, Science, vol.339, pp.1546-1558, 2013. ,
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets, Nat Genet, vol.47, pp.505-511, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01159736
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer, Nat Genet, vol.48, pp.500-509, 2016. ,
Intratumor heterogeneity in hepatocellular carcinoma, Clin Cancer Res, vol.21, pp.1951-1961, 2015. ,
Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma, Gastroenterology, vol.150, pp.998-1008, 2016. ,
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions, Nat Commun, vol.4, p.2218, 2013. ,
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis, Hepatology, vol.60, pp.1983-1992, 2014. ,
Inflammatory cytokines promote the retrodifferentiation of tumorderived hepatocyte-like cells to progenitor cells, Hepatology, vol.60, pp.2077-2090, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01134747
Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma, Gastroenterology, vol.151, pp.607-615, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01398435
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling, Cell, vol.155, pp.384-396, 2013. ,
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis, Gastroenterology, vol.152, pp.745-761, 2017. ,
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation, Cancer Cell, vol.25, pp.428-441, 2014. ,
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance, Hepatology, vol.68, pp.103-112, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01744935
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification, J Hepatol, vol.67, pp.727-738, 2017. ,
Fibrous nests" in human hepatocellular carcinoma express a Wntinduced gene signature associated with poor clinical outcome, Int J Biochem Cell Biol, vol.81, pp.195-207, 2016. ,
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling, Hepatology, vol.40, pp.667-676, 2004. ,
Application of comparative functional genomics to identify best-fit mouse models to study human cancer, Nat Genet, vol.36, pp.1306-1311, 2004. ,
Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver, Am J Pathol, vol.154, pp.1047-1055, 1999. ,
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype, J Clin Invest, vol.116, pp.1582-1595, 2006. ,
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nat Med, vol.12, pp.410-416, 2006. ,
Estimation of principal components and related models by iterative least squares, Krishnaiah PR. Multivariate analysis, pp.391-420, 1966. ,
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets, Hepatology, vol.45, pp.42-52, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00130313
Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection, Hepatology, vol.66, pp.1502-1518, 2017. ,
Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK), J Natl Cancer Inst, vol.97, pp.1180-1184, 2005. ,
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration, PLoS Med, vol.9, 2012. ,
Genotype-phenotype correlation of CTNNB1 mutations reveals different ?-catenin activity associated with liver tumor progression, Hepatology, vol.64, pp.2047-2061, 2016. ,
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation, Hepatology, vol.66, 2017. ,
Axin and hepatocellular carcinomas, Nat Genet, vol.24, pp.206-208, 2000. ,
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1, Nat Genet, vol.24, pp.245-250, 2000. ,
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas, Oncogene, vol.26, pp.774-780, 2007. ,
deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of ?-catenin activation, J Hepatol, vol.68, pp.1203-1213, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01807225
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nat Genet, vol.44, pp.694-698, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00719917
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas, Proc Natl Acad Sci, vol.101, pp.17216-17221, 2004. ,
The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion, Medicine (Baltimore), vol.95, 2016. ,
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma, Gastroenterology, vol.140, 2011. ,
Trunk mutational events present minimal intra-and inter-tumoral heterogeneity in hepatocellular carcinoma, J Hepatol, vol.67, pp.1222-1231, 2017. ,
Liver cancer: Translating '-omics' results into precision medicine for hepatocellular carcinoma, Nat Rev Gastroenterol Hepatol, vol.14, pp.571-572, 2017. ,
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma, Cancer, vol.68, pp.6779-6788, 2008. ,
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-7392, 2009. ,
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib, Clin Cancer Res, vol.18, pp.4997-5007, 2012. ,
Role of p53 and ?-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma, J Gastrointest Surg, vol.15, pp.321-329, 2011. ,
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis, Clin Cancer Res, vol.4, pp.1475-1482, 1998. ,
The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan, Hepatology, vol.22, pp.1702-1707, 1995. ,
Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas, Cancer Res, vol.61, pp.45-49, 2001. ,
Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas, Hepatology, vol.34, pp.82-88, 2001. ,
ADAM12 in human liver cancers: TGFbeta-regulated expression in stellate cells is associated with matrix remodeling, Hepatology, vol.37, pp.1056-1066, 2003. ,
Wholegenome sequencing identifies recurrent mutations in hepatocellular carcinoma, Genome Res, vol.23, pp.1422-1433, 2013. ,
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, pp.957-967, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00690471
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas, Oncotarget, vol.7, pp.39026-39043, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01335675
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma, Br J Cancer, vol.99, pp.143-150, 2008. ,
Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver, Nature, vol.524, pp.180-185, 2015. ,
Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/?-catenin signalling pathway, Gut, vol.60, pp.1635-1643, 2011. ,
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation, J Hepatol, vol.63, pp.1368-1377, 2015. ,
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features, Gastroenterology, vol.153, pp.812-826, 2017. ,
Hepatocellular carcinoma in the era of immunotherapy, Curr Probl Cancer, vol.42, pp.40-48, 2018. ,
Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes, Clin Cancer Res, vol.24, pp.1518-1524, 2018. ,
The immunology of hepatocellular carcinoma, Nat Immunol, vol.19, pp.222-232, 2018. ,
Gene-expression signature of vascular invasion in hepatocellular carcinoma, J Hepatol, vol.55, pp.1325-1331, 2011. ,
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients, Cancer Res, vol.70, pp.10202-10212, 2010. ,
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study, Gut, vol.65, pp.861-869, 2016. ,
Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma, Cancer Res, vol.70, pp.3034-3041, 2010. ,
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma, Cancer Res, vol.68, pp.1451-1461, 2008. ,
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features, Gastroenterology, vol.136, pp.1012-1024, 2009. ,
Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer, Hepatology, vol.47, pp.2059-2067, 2008. ,
The emerging role and targetability of the TCA cycle in cancer metabolism, Protein Cell, vol.9, pp.216-237, 2018. ,
Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects, World J Gastroenterol, vol.22, pp.9933-9943, 2016. ,
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics, Cancer Res, vol.73, pp.4992-5002, 2013. ,
A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma, Hepatology, 2017. ,
Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification, Hepatology, vol.58, pp.229-238, 2013. ,
Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma, Cell Mol Gastroenterol Hepatol, vol.4, pp.303-323, 2017. ,
?-catenin-activated hepatocellular carcinomas are addicted to fatty acids, Gut, 2018. ,
, Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, vol.169, pp.1327-1341, 2017.
Mutant IDH inhibits HNF-4? to block hepatocyte differentiation and promote biliary cancer, Nature, vol.513, pp.110-114, 2014. ,
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies, Cancer, vol.7, pp.462-503, 1954. ,
Who classification of tumours of the digestive system, 2010. ,
Neoplasms of the liver, Mod Pathol, vol.20, issue.1, 2007. ,
Deciphering liver zonation: new insights into the ?-catenin, Tcf4, and HNF4? triad, Hepatology, vol.59, pp.2080-2082, 2014. ,
Differential gene expression in periportal and perivenous mouse hepatocytes, FEBS J, vol.273, pp.5051-5061, 2006. ,
Liverspecific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver, Mol Endocrinol, vol.22, pp.1274-1286, 2008. ,
T-cell factor 4 and ?-catenin chromatin occupancies pattern zonal liver metabolism in mice, Hepatology, vol.59, pp.2344-2357, 2014. ,
Application of texture analysis to muscle mri: 1-what kind of information should be expected from texture analysis?, EPJ Nonlinear Biomed Phys, vol.3, p.3, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01140159
Application of texture analysis to muscle mri: 2 -technical recommendations, EPJ Nonlinear Biomed Phys, vol.3, issue.2, 2015. ,
,